Brain+ Investor Relations Material
Latest events
H1 2024
Brain+
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Brain+
Access all reports
Brain+ A/S, identified by the stock symbol BRAINP, is a healthcare company based in Copenhagen, Denmark, specializing in health information services. The company focuses on the development of digital therapeutics for Alzheimer's and dementia. Its product pipeline includes a variety of solutions aimed at cognitive stimulation therapy (CST) and computerized cognitive training for patients with mild cognitive impairment or early stages of Alzheimer's. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Copenhagen Stock Exchange.
Key slides for Brain+
Status Update
Brain+
Status Update
Brain+
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
BRAINP
Country
🇩🇰 Denmark